BIOTRILLION
DEAD

Serial Number

97261958

Owner

BioTrillion, Inc.

Attorney

Caroline Chicoine

First Use Date

Jan 1, 2018

Filing Date

Feb 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BIOTRILLION Trademark

Serial Number: 97261958

BIOTRILLION is a trademark filed by BioTrillion, Inc. on February 10, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BioTrillion, Inc. (14 trademarks)

338 Spear Street, 29C
San Francisco, CA 94105

Entity Type: 03

Trademark Details

Filing Date

February 10, 2022

Registration Date

Not Registered

First Use Anywhere

January 1, 2018

First Use in Commerce

June 5, 2024

Published for Opposition

September 5, 2023

Goods & Services

downloadable computer software platforms for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; Downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiological data; Downloadable computer software platforms for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; Downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, or drug effects or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; Downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data

Software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; software as a service (SAAS) services featuring software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; software as a service (SAAS) services featuring downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, drug effects or drug use

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 27, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 27, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 2, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 2, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 15, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 15, 2025 AITU
USE AMENDMENT FILED
Oct 29, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 29, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 16, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 15, 2024 EX1G
SOU EXTENSION 1 FILED
Apr 15, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 15, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 31, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 3, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 6, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 6, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 5, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2022 NWOS
NEW APPLICATION ENTERED
Feb 14, 2022 NWAP